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Abstract: The focus of this study was to review existing literature and analyze 
a survey of professional opinion regarding how children with hearing loss 
caused by congenital cytomegalovirus (CMV) function audiologically and 
educationally. This study proposes a benefit for adding CMV screening to the 
battery of tests included in the newborn screening protocol to improve 
educational outcomes of children deafened from CMV.  
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Congenital cytomegalovirus (CMV) is a common virus that can cause disease in babies 
infected before birth.  Congenital CMV can adversely affect the physical health and cognitive 
growth of the infected child. Of the 40,000 infants in the United States annually infected with 
congenital CMV, 6,000 develop sensorineural hearing loss (SNHL) (Dahle, Fowler, & Wright, 
2000). In the United States, approximately 12,000 infants per year are born deaf or hard of 
hearing. Therefore, 50% of infants who present with hearing loss at birth have hearing loss as a 
result of congenital CMV. Congenital CMV is speculated to be the leading nongenetic cause of 
congenital hearing loss. Even though congenital CMV contributes as a major cause of hearing 
loss, Universal Newborn Hearing Screening (UNHS) alone may not detect all cases of hearing 
loss caused by congenital CMV (Fowler, Dahle & Bopanna, 1999). Approximately 90% of 
infants infected with congenital CMV are asymptomatic at birth—presenting without symptoms. 
These infants may pass their hearing screening but suffer from late onset or progressive hearing 
loss; common hearing loss patterns in this population (Fowler & Boppana, 2006). Universal 
newborn screening programs do not currently include CMV; however, CMV is more common 
than all other disorders included in the newborn screening program and is a leading cause of 
disability in children (Grosse, Dollard, Ross & Cannon, 2009). Perhaps a more comprehensive 
UNHS program, one with universal newborn CMV screening, would provide more benefit to 
detecting infants “at risk” of developing hearing loss.  
To investigate to what extent congenital CMV causes disability, literature was reviewed 
analyzing language, speech, cognitive and motor function in children with symptomatic or 
asymptomatic congenital CMV. The literature reports adverse affects on speech, language, 
cognition and motor function in children diagnosed with congenital CMV. The following 
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literature review and study aims to analyze existing information and professional opinion as to 
the benefits of including CMV screening among the newborn screening protocol. With this 
knowledge, adequate intervention and monitoring of hearing status could be provided to all 
children affected by congenital CMV, whether they are symptomatic or asymptomatic at birth.  
UNDERSTANDING CONGENITAL CMV 
 Ross, Dollard, Victor, Sumartojo, and Cannon (2006) defined CMV as “a large DNA 
virus belonging to the Herpesviridae family and can be transmitted through contact with infected 
blood, tissues and bodily fluids.”  CMV infections occur in all human populations more frequent 
depending on socioeconomic and ethnic status of populations. African American, inner city 
populations have a higher incidence of the disease (Schleiss & Choo, 2006). Evidence of past 
infection occurs in 50% of adults in developed countries and 90-100% in developing countries 
(Ross & Bopanna, 2004). The Centers for Disease Control and Prevention states that most 
healthy people experience no symptoms associated with CMV infection. A small percentage of 
adults who contract CMV do experience mild symptoms, similar to a mononucleosis-like 
syndrome. CMV poses a problem for certain high-risk groups including unborn babies whose 
mothers become infected with CMV during pregnancy and children or adults with compromised 
immune systems (El-Din, 2008). Maternal immune status can determine the likelihood and 
severity of the disease in the newborn. For example, if primary maternal infection occurs during 
pregnancy, the average rate of transmission to the fetus is 40% and decreases between 0.5-1.5% 
with recurrent maternal infection. In either of those cases, congenital CMV could present as 
symptomatic or asymptomatic; in other words, with or without clinical manifestations of the 
disease at birth (El-Din, 2008).  
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 CMV can be detected in the urine, blood, and/or saliva and can be diagnosed in the 
mother, congenital fetus, and newborn (Revello & Gerna, 2002). Newborns are not currently 
routinely screened for CMV infection (Ross, Dollard, Victor, Sumartojo & Cannon, 2006). 
According to Grosse, Dollard, Ross & Cannon (2009), “CMV screening for newborns suspected 
of having congenital CMV is often conducted as part of clinical practice, although not 
consistently.” In order to properly identify congenital CMV, samples of urine, blood, and/or 
saliva must be taken within the first two weeks of life. After the first two weeks of life virus 
excretion may represent neonatal infections acquired in the birth canal or following exposure to 
breast milk or blood products (Revello & Gerna, 2002).  
 The clinical findings of congenital CMV (symptomatic) include petechiae, tiny red dots 
resembling a rash due to broken blood vessels; jaundice, yellowing of the skin and whites of the 
eyes due to excessive bilirubin; microcephaly, an abnormally small head and underdeveloped 
brain; seizures, convulsions due to abnormal brain activity; sensorineural hearing loss, hearing 
loss caused by damage to the inner ear and/or nerve pathways, and mental retardation to name a 
few (Ross & Bopanna, 2004). Prevention of the transmission of CMV to pregnant women 
represents a safe, effective and simple intervention. Prevention includes practicing good hygiene; 
hand washing and eliminating exposure to an infected child’s urine or mucus (Cannon & Davis, 
2005). Several vaccines for adolescents and adults are currently being tested but not yet available 
(Ross et al., 2006). Antiviral drugs, such as glanciclovir are being considered and trialed as 
treatment. Glanciclovir can be used to treat neonates or infants with congenital CMV disease 
(Adler, Nigro & Periera, 2007). The evidence of said antiviral drugs is undefined due to lack of 
data (Revello & Gerna, 2002). Early intervention, in addition to medical treatment, is vital as a 
form of treatment not only for CMV but for SNHL as well. Left undetected, hearing impairment 
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in infants can negatively affect speech and language acquisition, academic achievement, and 
social and emotional development. These negative effects can be reduced through early 
intervention (Declau, Boudewyns, Van den Ende, Peeters & Van den Heyning, 2008).  
SENSORINEURAL HEARING LOSS AND CMV 
Permanent central nervous system defects characterize a large amount of congenital 
CMV infections. Central nervous system sequelae include sensorineural hearing loss (SNHL). 
The American Speech and Hearing Association (ASHA) defines SNHL as damage to the inner 
ear (cochlea), and or the nerve pathways from the inner ear to the brain. Of the 40,000 infants in 
the United States annually infected with CMV, upward of 6,000 develop SNHL during early 
maturation. CMV accounts for 21% of all hearing loss at birth and 25% more is late onset; these 
numbers suggest that CMV is the leading nongenetic congenital cause of hearing loss (Dahle et 
al., 2000).  Schleiss & Choo (2006) stated “more infants suffer hearing impairment caused by 
congenital CMV infection than was caused by either rubella syndrome or…meningitis in the 
prevaccine era for those infectious diseases”.  
 At the University of Alabama, Dahle et al. (2000) conducted a longitudinal study to 
investigate the effects of congenital CMV infection on hearing sensitivity. The study included 
860 children with documented asymptomatic or symptomatic congenital CMV infection. These 
children were born between 1966 and 1999 and identified either by referral or as part of routine 
newborn CMV screening at two hospitals in Birmingham. SNHL occurred in 7.4% of the 
asymptomatic children and 40.7% of the symptomatic children. Of these children with SNHL, 
the majority had severe or profound loss (68% of asymptomatic children and 74% of 
symptomatic children). With regards to both groups (asymptomatic and symptomatic) children 
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experienced delayed onset of loss, threshold fluctuations, and/or progressive hearing loss. 
Progression or further deterioration of loss occurred in over 50% of both groups. These results 
support previous findings indicating that CMV infection often results in late onset and 
progressive hearing loss (Fowler & Boppana, 2006).  
Fowler & Boppana, recorded the onset of hearing loss to be between 33 months of age 
and 44 months of age—a critical period for speech and language development (Sharma & 
O’Sullivan, 2011). The impact of hearing loss on speech and language development is great 
(Walter et al, 2007) which supports that predicting hearing loss may speed up early intervention, 
in turn increasing positive educational outcomes. Fowler & Boppana investigated possible risk 
factors to predict which children with CMV will develop hearing loss or if that hearing loss will 
progress. The population included 504 children with asymptomatic CMV comparing risk factors 
of those who developed SNHL to those who did not. Children with SNHL were more likely to be 
preterm and to have a slightly lower mean birth weight. In the Rivera et al. study (2002), clinical 
manifestations of symptomatic CMV were examined to evaluate whether these factors could 
predict which children would develop SNHL. After adjusting for race, insurance status, 
intrauterine growth retardation, petechiae, hepatosplenomegaly, jaundice, microcephaly, 
seizures, thrombocytopenia, and referral status, only petechiae independently predicted hearing 
loss. Fowler & Boppana (2006) evaluated whether an infant’s viral burden, that is the 
concentration of the virus, in the neonatal period could predict hearing loss due to CMV and 
suggests that an increased viral burden in infancy might identify those children with 
asymptomatic infection who are at increased risk for hearing loss. In all of the above studies, it 





SCREENING FOR CMV 
 Currently, 29 recommended tests compose newborn screenings as described by national 
guidelines. The Missouri newborn screening panel included 27 of the 29 recommended screening 
disorders (Missouri Department of Health and Senior Services). The goal is to identify 29 
potentially treatable congenital disorders which may cause life-threatening health problems if not 
detected. Individual states can decide how many of these tests to include, but must include: 
Phenylketonuria (PKU), Congenital hypothyroidism (CH) and Galactosemis (GAL) (“Screening 
Tests”, 2008). Screening for congenital CMV is not included in the current panel of newborn 
tests, however congenital CMV meets certain criteria for newborn screening: CMV is more 
common than all other disorders included in the newborn screening program and is a leading 
cause of disability in children (Grosse, Dollard, Ross & Cannon, 2009).  
Screening for congenital CMV is integrated in the TORCH (toxoplasmosis, rubella, 
cytomegalovirus, and herpes simplex virus) panel. The TORCH panel is only performed on 
newborns who have certain symptoms or born to mothers who may have been exposed to certain 
pathogens—missing children who have asymptomatic congenital CMV infection (Lab Tests 
Online). “Knowledge regarding the etiology of a child’s deafness is important…such information 
will help to predict whether the level of HL will remain stable or progressively worsen over 
time” (Pierson et al., 2007). Declau, Boudewyns, Van den Ende, Peeters & van den Heyning 
(2008) completed etiologic evaluations on 170 newborns with confirmed congenital hearing loss. 
Results showed CMV was identified in 18.8% of children proving etiologic evaluations 
beneficial. With etiologic understanding, these infants can be monitored consistently for SNHL.  
 6
Humphrey 
Samples must be taken within the first 2 weeks of life to determine if the CMV infection 
was actually congenital. Since early identification may lead to early intervention, a simple and 
inexpensive assay for CMV detection is required to implement screening programs for 
congenital CMV infection (Revello & Gerna, 2002). Considering that 90% of infected newborns 
are asymptomatic at birth and after the newborn period, congenital CMV screening at birth is 
essential (Fowler & Boppana, 2006). CMV screening is minimally invasive and there are 
currently three methods used to test; urine, blood and saliva. Urine analysis is the most widely 
used form of screening, but storage and shipping to a laboratory present difficulty. Saliva 
analysis is easier than urine analysis and just as reliable (Balcarek et al, 1993). Dried Blood 
Spots (DBS) are of increasing interest as a screening method because DBS are routinely 
collected at birth. Simple, fast, inexpensive and easily stored yet limited by low sensitivity in its 
value as a screening test. 
 The main disability in children resulting from congenital CMV is SNHL so it has been 
assumed that universal newborn hearing screening alone will identify these at risk children. 
Fowler, Dahle, Boppana & Pass (1999) routinely evaluated hearing status in a cohort of 388 
children born between 1980 and 1986 with confirmed congenital CMV. Within this population, 
less than half (5.2%) with SNHL were detected by newborn hearing screening. By 72 months, 
15.4% of children with confirmed congenital CMV had documented SNHL. These findings give 
a startling picture of how many children with congenital CMV are at risk for developing 
potentially unnoticed and untreated late onset SNHL. Undetected and untreated SNHL cause 
speech, language and learning setbacks (Cole & Flexer, 2007). Schleiss and Choo (2006) agree 
that in order to instill a comprehensive early hearing loss identification program, universal 
screening of all infants for CMV should be included. Best said by Moeller et al. (2010): 
 7
Humphrey 
“Knowledge of the risk factors for late-onset hearing loss and continued vigilance in screening, 
monitoring and referral are vital”.  
EDUCATIONAL OUTCOMES 
 Considering that congenital CMV is a leading cause of hearing loss and hearing loss is 
detrimental to speech, language and learning, it may be of interest to look at the educational 
outcomes in children with congenital CMV. The following studies aim to portray children with 
congenital CMV regardless of hearing status. Children with congenital CMV may be 
symptomatic or asymptomatic at birth. The majority of the following studies focus on 
educational outcomes of children with symptomatic congenital CMV. These results are 
important to consider when looking at children with asymptomatic congenital CMV; children 
with asymptomatic congenital CMV may be at risk for any or all of these negative educational 
outcomes. The strong correlation between low intellectual development and symptomatic 
congenital CMV suggest that the population of children with asymptomatic congenital CMV 
may be affected in a more subtle manner (Conboy et al., 1986).  
 Madden et al. (2005) studied a cohort of 21 patients with symptomatic congenital CMV 
and diagnosed SNHL. These children’s clinical data, audiometric thresholds, radiographic 
abnormalities, communication and educational achievements were used as outcome measures. 
Average age of participants was 12 years old. Of the 21 participants a variety of educational 
settings were observed with the majority of children in special needs settings: 19% mainstream 
setting, 24% school for the deaf, 9% hearing impaired classroom, and 48% special needs setting. 
Communication modes included manual communication (7), total communication (9) and oral 
communication (5). The use of non oral communication was significantly associated with the 
 8
Humphrey 
presence of mental retardation. Results concluded that children with evidence of neurologic 
disease were significantly associated with the need for greater educational support. These 
findings are particularly true of children with a history of microcephaly, cerebral palsy and 
mental retardation. 
 Noyola et al. (2001) investigated neurodevelopmental outcome in symptomatic 
congenital CMV. Patient population included 41 children diagnosed with symptomatic 
congenital CMV who were enrolled in a previous study; the Houston CMV longitudinal follow-
up study. Evaluation of participants included age-appropriate neurodevelopmental assessments. 
Assessments consisted of: Bayley Scales of Infant Development, Kaufman Assessment Battery 
for Children and the Wechsler Intelligence Scale for Children Revised. Intelligence quotients 
were reported as follows: 29.9% with an IQ>90, 24.3% with an IQ 70-89, 9.7% with an IQ 50-
69, 36.5% with an IQ<50. In addition 36.5% of the population presented with a major motor 
disorder. Microcephely was the most specific predictor of mental retardation. Of this population 
with symptomatic congenital CMV, 28 children were diagnosed with SNHL. These 28 children 
were compared to the remaining 13 children with normal hearing. A significant difference in 
cognition and motor skills were noted; 50% of the children with SNHL display motor disability. 
The mean IQ of the children with SNHL was 65.3.  
 Zhang et al. (2007), conducted a longitudinal study researching physical and intellectual 
development in children with asymptomatic congenital CMV infection. The study took place in 
the Qinba mountain area, China. Unique to this study, the Qinba mountain area has a high 
incidence of mental retardation and high incidence of CMV active infection in pregnancy (Yan et 
al.., 2000). The participants included 49 children born between 1997 and 2000 and diagnosed 
with CMV infection within the first week of life but presented with no symptoms. Although the 
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article recognizes SNHL as a manifestation of CMV, the study population does not distinguish 
between those with SNHL and those without. The participants were matched with 50 control 
subjects by age, race, school grade, parent education and socioeconomic status and tested over a 
four year period. Testing methods included different scales according to age; Gesell 
Developmental Schedule for infants between 18 and 36 months corrected age and the Wechsler 
Preschool and Primary Scale of Intelligence (WPPSI) for preschool children between 48 and 72 
months. Results on the Gesell Developmental Schedule were measured by Developmental 
Quotient (DQ). The delay in language development in the infection group was of statistical 
significance. Results on the WPPSI found significant differences in full-scale and verbal IQ 
scores between asymptomatically infected children and the controls proving a significant 
difference in cognition. The results of this study suggest cognitive function and language 
development may be compromised in these individuals—regardless of hearing status.  
SUMMARY OF LITERATURE REVIEW 
The goal of this literature review was to examine the value of mandatory universal 
newborn screening for CMV. The above review of literature supports a benefit to such screening.  
Congenital CMV accounts for 21% of all hearing loss at birth and 25% more is late onset 
(Dahle et al., 2000). CMV can be symptomatic or asymptomatic, that is with or without 
symptoms present at birth. Symptomatic newborns will be tested for CMV, but asymptomatic 
newborns will not automatically be tested for CMV. Newborns that refer on newborn hearing 
screening will also be tested for CMV. Since both asymptomatic CMV and late onset hearing 
loss are characteristic of CMV, a large amount of infants with CMV will be missed (Fowler, 
Dahle, Boppana & Pass, 1999). A comprehensive newborn screening program including CMV 
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screening would identify infants “at risk” of developing late onset SNHL. SNHL adversely 
affects speech and language acquisition, academic achievement, and social and emotional 
development. These negative effects can be reduced through early detection leading to early 
intervention such as counseling and audiologic monitoring and management (Declau et al., 
2008).  
Life-threatening health problems and serious lifelong disabilities can be avoided or 
minimized through newborn screening of congenital disorders. For a disorder to qualify to be 
added to newborn screening, it must be more common than all other disorders included in current 
screening and must be a leading cause of disability in children. Congenital CMV is more 
common than all other disorders included in the newborn screening program and is a leading 
cause of disability in children (Grosse et al., 2009). CMV screening is a potentially inexpensive, 
minimally invasive way to predict and minimize complications surrounding congenital CMV. 
The virus is only proven to be congenital within the infants first two weeks for life, therefore 
must be screened at birth (Revello & Gerna, 2002). 
 The aforementioned research studies all shed negative light on educational outcomes for 
children with CMV. Madden et al. (2005) studied symptomatic children with CMV and hearing 
loss and concluded that the majority of children were educated in a support setting other than the 
mainstream. Noyola et al. (2001) investigated neurodevelopmental outcome in 41 children with 
symptomatic CMV regardless of hearing status. This study reported a significant percentage of 
children with low IQ scores and major motor disability. 28 children were diagnosed with SNHL 
and compared to the remaining 13 children with normal hearing, a significant difference in 
cognition and motor skills were noted. Zhang et al. (2007) researched physical and intellectual 
development in children with asymptomatic CMV as compared with a like group of children 
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without CMV. The children with asymptomatic CMV displayed significant delay in language 
and cognition. These studies illustrate just how different children with CMV may be from 
typically developing children. The research provides insight into what sort of additional 
educational needs these children require. Early detection through screening will likely lead to 
early intervention; early intervention will likely improve educational outcomes in this 
population.  
SURVEY 
 The above literature review supports the idea that children with congenital CMV have 
additional audiologic and educational needs which not only suggest a need for newborn 
screening but also additional support in the school environment. To investigate whether children 
with a confirmed or suspected diagnosis of CMV, particularly those with hearing loss, exhibited 
additional needs, the examiner surveyed teachers of the deaf in OPTION schools throughout the 
nation. OPTION schools are private Listening and Spoken Language schools dedicated to 
providing services to teach children who are deaf to listen and talk. The examiner also 
determined teachers’ knowledge surrounding CMV and inquired about what sort of additional 
information would help them educate children with CMV. The examiner used a ten question 
survey as a gauge of teacher opinion to examine if classroom observations coincided with the 
literature.  Hopefully this survey will provide a greater understanding of how children with CMV 
behave in the classroom environment. The information gathered in this study may benefit 
teachers of the deaf by drawing attention to the fact that children with congenital CMV require 
specialized instruction in addition to that typically offered to children diagnosed with a hearing 




Participants and Procedures 
The examiner designed a survey using the online survey database, Survey Monkey. The 
survey was comprised of 10 questions and available from 2/16/2012 to 5/5/12.  The questions 
were meant to determine each participants experience teaching children with CMV and to 
determine how children with CMV behaved and the accommodations they required (See 
Appendix A). The examiner recruited participants by e-mailing the designated contact for all 47 
OPTION schools listed at www.auditoryoral.org . Of these 47 schools, 7 contacts replied and 
agreed to distribute the survey link to their staff.  21 surveys were collected. One survey was 
excluded based on inconsistent answers. Of the 20 included surveys, 15 participants answered 
that they had taught a child with CMV over the course of their career. The data in these 15 
surveys were analyzed regarding their answers to the follow-up questions. The remaining 5 
participants answered either “no” or “I don’t know”. Of theses 5 participants, no one completed 
the follow-up questions regarding disabilities and accommodations; however they provided 
information relating their own knowledge of CMV and their perceived ability to teach children 
with CMV. 
RESULTS 
 In response to the question “Have you ever heard of congenital cytomegalovirus 
(CMV)?” 25% (5 out of 20) stated “I have heard of CMV and feel knowledgeable on the topic” 
and 70% (14 out of 20) stated “I have heard of CMV but do not feel knowledgeable on the 
topic”. The 5 participants who had never had a child with CMV in their class unanimously 
answered that they do not feel knowledgeable about CMV. The subsequent question asked 
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participants to explain CMV to the best of their knowledge. Only 19 participants chose to 
complete this question. The majority, 53% (10 out of 19), of responses included the words (or 
other closely related words) “virus, pregnant, hearing loss”. 42% (8 out of 19) mentioned 
additional developmental delays.  
 The next question, “Have you ever taught a child with congenital CMV?” yielded 70% 
(14 out of 20) “yes” responses and 24% (5 out of 20) negative responses. The next question was 
a follow up question that inquired about observed CMV symptoms. The question stated, “For the 
children you have taught with CMV, check the following that apply” and included a table with 8 
known symptoms of congenital CMV. The symptoms included: progressive hearing loss, vision 
loss, gross motor delay, fine motor delay, balance problems, speech deficit (greater than a 
hearing impaired child without CMV) and language deficit (greater than a hearing impaired child 
without CMV). Participants were asked to check “yes” corresponding to each symptom they 
observed.  Table 1 represents the results collected from the 14 participants who answered “yes” 
to having taught a child with congenital CMV. The remaining 5 participants answered “no” or “I 
don’t know” to having taught a child with CMV did not answer the questions regarding observed 
behavior. 
The next question inquired whether the participants thought children with CMV required 
specialized services or a different approach to instruction. 65% (13 out of 20) answered “yes” 
and 20% (4 out of 20) answered “no”. As a follow-up question, the participants were asked to 
record which additional services children with CMV required. 6 common services relating to 
known symptoms of CMV were listed. The services are: Occupational Therapy (OT), Physical 
Therapy (PT), Speech Language Pathology (SLP), Manual Communication, Modified 
Curriculum and Visual Accommodations. Table 2 depicts the results from the 14 participants 
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who had taught a child with CMV. The remaining 5 participants had never (to their knowledge) 
taught a child with CMV. These participants did not answer the questions regarding observed 
services.  
For the question, “My knowledge of CMV is adequate to provide appropriate educational 
services to the students I serve” 40% (8 out of 20) agreed, 30% (6 out of 20) did not agree, and 
30% (6 out of 20) said “maybe”. Subsequently an open-ended question was used to determine 
what additional information regarding CMV would be helpful. Only 11 participants answered 
this question. 73% (8 out of 11) responses indicated they wanted to know more about how CMV 
affects education and what sort of accommodations or strategies children with CMV need. Of 
these results, verbatim answers included “Basic information on causes, symptoms and 
educational implications”, “I’d like to know more about what delays, academic difficulties, to 
expect and suggested accommodations”, “more information on the areas of development that are 
affected by CMV, how to address their needs in the classroom”, and “If there are studies that 
show specific strategies work best with children with CMV”.  
DISCUSSION 
Research suggests children with congenital CMV present with significant cognitive and 
language deficits. This survey aimed to investigate whether children with a confirmed or 
suspected diagnosis of CMV, particularly those with hearing loss, exhibited additional 
educational needs. In addition, this survey evaluated teachers’ knowledge surrounding CMV and 
what sort of additional information would help them educate children with CMV. This ten 
question survey, offered as a measure of teacher opinion, was used to determine if classroom 
observations matched with the literature. Results from the survey suggest children with CMV 
 15
Humphrey 
and hearing loss do in fact exhibit an assortment of symptoms characteristic of CMV that require 
additional educational support.  
Considering that CMV is the leading nongenetic cause of hearing loss, it is extremely likely  
teachers of the deaf have or will have a child with congenital CMV in their class. This study 
revealed 5 out of 20 participants stating they had either never had a child with CMV in their class 
or that they didn’t know if they had. The examiner speculates this is due to a lack of diagnosis 
which is a direct result of no universal screening at birth. Those particular participants who said 
“no” to having taught a child with CMV also stated: “I have heard of CMV but do not feel 
knowledgeable on the topic”. Perhaps the participants who had taught a child with CMV before 
were prompted to review that child’s case history and research CMV whereas the participants 
without a child with CMV never felt that need.  
Questions regarding observed symptoms and accommodations of children with congenital 
CMV aimed at understanding how children with congenital CMV function in the school 
environment. In addition, the examiner wanted to investigate how participant’s observations 
compared to the literature. Due to lack of knowledge of the children observed, differences in 
symptomatic or asymptomatic CMV is unknown; however interesting parallels between findings 
and the literature can be noted. Noyola et al. (2001) reported low IQ scores and 36.5% of the 
population displayed major motor disability. 93% of participants observed major motor problems 
in children with CMV. Not surprisingly, participants of the survey stated 71% of children they 
observed with CMV required physical therapy and 83% required occupational therapy. A 
common sequelae of CMV is cerebral palsy which could attribute to the motor disorders in 
children with CMV. Zhang et al. (2007) researched physical and intellectual development in 
children with asymptomatic congenital CMV as compared with a like group of children without 
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CMV. The children with asymptomatic congenital CMV displayed significant delay in language.  
In the survey, greater than half of participants observed a language delay beyond what would be 
expected in children with hearing loss in children with congenital CMV. 71% of students 
required additional support of a Speech Language Pathologist.  
60% of participants did not agree or answered “maybe” to the question: “My knowledge of 
CMV is adequate to provide appropriate educational services to the students I serve”. When 
asked to expand on their reply, 73% of responses indicated they wanted to know more about how 
CMV affects education and what sort of accommodations or strategies children with CMV need. 
These answers demonstrate that teachers may not have an adequate level of knowledge 
pertaining to CMV which indicates two things; teachers of the deaf need to be better educated 
about CMV and more research needs to surround educational needs of children with CMV. The 
teachers want more information, however, information is lacking due to minimal studies on the 
topic of educational outcomes in children with congenital CMV. The small number of studies 
can be explained by the fact that children with CMV are a difficult study population. Many 
children with CMV are undiagnosed due to lack of universal screening at birth. A universal 
screening program at birth would allow for a larger study population and ultimately benefit 
infected infants and their families.  
Limitations  
This survey included 20 participants from 7 schools. A reason only 7 schools may have 
participated was due to their inexperience with CMV and decision not to partake in a study about 
CMV. Another speculation is that contact e-mails for the schools were incorrect or never 
forwarded to an accurate contact. Only OPTION Schools were asked to participate to narrow the 
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population. OPTION Schools use the auditory oral mode of communication which is only one 
representation of communication options for children who are hearing impaired. These schools 
are not a comprehensive representation of children who are hearing impaired. In fact, hearing 
impaired children who attend Option schools typically need additional educational support as 
compared to hearing impaired children who attend mainstream schools. Additionally, the 
literature points to the need for a significant number of children with congenital CMV to 
communicate using sign language or another visual communication mode, therefore, it is likely 
that a large percentage of children who have SNHL as a result of congenital CMV are not 
education in OPTION Schools that only utilize listening and spoken language for 
communication. 
This was a survey based on observations and opinion therefore no factual data was 
reported. Only those teachers who had experience teaching hearing impaired children with CMV 
completed the observation portion of the survey. They drew upon their experience to answer 
these questions, meaning that only a small group of students with CMV were considered—not a 
solid representation of children with CMV. Arguably, these results give an idea of how children 
with hearing loss and CMV function in their academic environment. Since the results were 
comparable with the literature, a larger scale survey may be useful. In addition since this survey 
did not include any comparisons, it would be beneficial to compare children with CMV and 
hearing loss to children with a differing etiology of hearing loss.  
CONCLUSION 
The purpose of this study was two-fold: To investigate whether adding CMV screening to 
universal newborn screening programs would benefit children who are at risk for developing 
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hearing loss and to explore how children with congenital CMV behave in an educational 
environment and whether specialized instruction is required. To explore these points, an 
exhaustive review of past and present research was compiled and an opinion survey was 
administered to teachers of the deaf reviewing their observations of children with congenital 
CMV and hearing loss.   
The included survey provides insight into how children diagnosed with congenital CMV 
and hearing loss behave in their educational environment as observed by teachers of the deaf. 
Results from the survey suggest children with CMV and hearing loss do in fact exhibit 
symptoms characteristic of CMV that require additional educational support. In addition, the 
participants were forthcoming in their desire for additional information concerning how best to 
educate children with hearing loss caused by congenital CMV. Currently, no research is 
dedicated to analyzing what kind of specialized instruction is needed for these children. 
Knowledge of specialized instruction as it pertains to this population of children could improve 
the field of deaf education.  This knowledge could provide educators with the resources and 
ability to best serve this population. 
In order to ensure appropriate research concerning educational outcomes of children 
diagnosed with congenital CMV, proper diagnosis of congenital CMV must occur. Upon review 
of the literature, evidence points to a major benefit of adding CMV screening to a universal 
newborn screening program. “Knowledge of the risk factors for late-onset hearing loss and 
continued vigilance in screening, monitoring and referral are vital” (Moeller et al., 2010). A case 
can be made for adding CMV to the battery of tests included in newborn screening. CMV is one 
of the most common viral causes of congenital infection and is the leading non-genetic cause of 
hearing loss, CMV meets important screening criteria, and congenital CMV may affect 
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educational outcomes in children. Screening for CMV at birth may accelerate early intervention 
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1. How many years have you been teaching children who are deaf and hard of hearing? 
2. Have you ever heard of congenital Cytomegalovirus (CMV)? 
3. To the best of your knowledge, describe CMV. 
4. Have you ever taught a child with congenital CMV? 
5. Do you currently have a child with congenital CMV in your class? 
6. For the children you have taught with CMV check the following that apply: 
a. Progressive hearing loss 
b. Vision loss 
c. Gross motor delay 
d. Fine motor delay 
e. Balance problems 
f. Speech deficit (greater than a hearing impaired child without CMV) 
g. Language deficit (greater than a hearing impaired child without CMV) 
h. Low IQ 
7. In your opinion, in comparison to children without CMV, did any of the children with 
CMV require specialized services or a different approach to instruction? 
8. If yes, which of the following apply: 
a. Occupational therapy 
b. Physical therapy 
c. Speech language pathology 
d. Use of sign language or fingerspelling 






9. My knowledge of CMV is adequate to provide appropriate educational services to the 
students I serve.  
a. I agree 
b. I do not agree 
c. Maybe  
10.  If you disagreed or checked ‘maybe’ to the above statement, please describe what 
additional information would be helpful.  
 
 
 
 
 
